A celebrated research project examining pregnant women who use opioids has faced sharp criticism. Independent auditors and medical experts uncovered major methodological flaws, casting doubt on its findings and influence on treatment guidelines.
The study, led by a prominent researcher, gained widespread attention for suggesting new approaches to treating opioid dependency in pregnancy. Media outlets and medical organizations highlighted its results, which appeared to show improved outcomes for mothers and babies. Funding and policy recommendations quickly followed the initial publication.
Auditors later reviewed the data and found inconsistencies in participant selection and outcome tracking. Experts pointed out that the sample size was too small and lacked proper controls, making the conclusions unreliable. Several co-authors have since distanced themselves from the work.
Health advocates now worry the flawed research may have misled doctors and patients. Calls for better oversight in addiction studies are growing. The researcher has defended the work but faces ongoing questions about its validity and long-term effects on care standards.
79.915 SRY